Trial intelligence / Profile preview

Levetiracetam ER add-on therapy for partial-onset seizures

CTR20150732Phase 2Suspended

Sponsor
Beijing Boshi Antai Technology Development
Start
Nov 2015
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of levetiracetam in epilepsy, sponsored by Beijing Boshi Antai Technology Development. Started Nov 2015; status: suspended.

02

Drugs

levetiracetam
03

Conditions

epilepsy

Beyond the preview

Go deeper on CTR20150732.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20150732.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call